Your browser doesn't support javascript.
loading
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.
Ito, Ayumu; Nakano, Nobuaki; Tanaka, Takashi; Fuji, Shigeo; Makiyama, Junya; Inoue, Yoshitaka; Choi, Ilseung; Nakamae, Hirohisa; Nagafuji, Koji; Takase, Ken; Machida, Shinichiro; Takahashi, Tsutomu; Sawayama, Yasushi; Kamimura, Tomohiko; Kato, Koji; Kawakita, Toshiro; Ogata, Masao; Sakai, Rika; Shiratori, Souichi; Uchimaru, Kaoru; Inamoto, Yoshihiro; Utsunomiya, Atae; Fukuda, Takahiro.
Affiliation
  • Ito A; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Nakano N; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Tanaka T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Fuji S; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
  • Makiyama J; Department of Hematology/Oncology, Institute of Medical Science, The University of Tokyo Hospital, Tokyo, Japan.
  • Inoue Y; Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan.
  • Choi I; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Nakamae H; Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
  • Nagafuji K; Department of Hematology and Oncology, Kurume University Hospital, Kurume, Japan.
  • Takase K; Department of Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Machida S; Department of Hematology and Oncology, Tokai University Hospital, Isehara, Japan.
  • Takahashi T; Department of Hematology, Shimane University Hospital, Izumo, Japan.
  • Sawayama Y; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Kamimura T; Department of Hematology, Harasanshin Hospital, Fukuoka, Japan.
  • Kato K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Ogata M; Department of Hematology, Oita University Hospital, Oita, Japan.
  • Sakai R; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Shiratori S; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan; and.
  • Uchimaru K; Department of Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Inamoto Y; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Utsunomiya A; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Blood Adv ; 5(20): 4156-4166, 2021 10 26.
Article in En | MEDLINE | ID: mdl-34500464
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia-Lymphoma, Adult T-Cell / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Adv Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia-Lymphoma, Adult T-Cell / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Adv Year: 2021 Document type: Article Affiliation country: Country of publication: